DUKE UNIVERSITY - Coronavirus Contracts

Contracts Vendors Agencies Categories States

Coronavirus Contracts

Tracking Federal Purchases to Fight the Coronavirus

Home › All Vendors › Vendor ›

DUKE UNIVERSITY

Total Committed Value of Federal Contracts

$12M

Total Contracts

Total Actions

Location

Durham, NC

Recent Contract Actions

Contracts can have multiple “contract actions”: This is how agencies spend money for a specific purpose, adjust the amount committed or change the contract in a way that doesn’t affect the amount. That last scenario is usually indicated by a $0 action. If there is a contract action for a negative amount, it generally means the contract was adjusted or canceled.

Description	Category	Agency	Signed	Amount Committed
THIS CONTRACT WILL SUPPORT COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES, BASED ON PRINCIPLES OF INFLUENZA IMMUNITY, THAT ACHIEVE DURABLE, ROBUST	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	April 20, 2021	$515,384
SHEPHERD 2011 DOMAIN 1-A001 VE	Physical Science Applied Research/Exploratory Development R&D	Centers for Disease Control and Prevention	March 10, 2021	$0
HHSN275201800008I/HHSN27500001 - POPULATION HEALTH RESEARCH SUPPORT/ TASK ORDER STUDY OF PREGNANCY AND NEONATAL HEALTH (SPAN) - DUKE UNIVERSITY - CAN 8473518	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	February 09, 2021	$0
FY 2020 COVID-19 BAA TOPIC 2 - DUKE	Physical Science Applied Research/Exploratory Development R&D	Centers for Disease Control and Prevention	February 02, 2021	$0
COVID-19: NONHUMAN PRIMATE CORE VIROLOGY LABORATORY FOR AIDS VACCINE RESEARCH AND DEVELOPMENT	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	December 18, 2020	$517,711
CISA COVID PEDIATRIC STUDY LEAD	Health R&D Services: Applied Research	Centers for Disease Control and Prevention	December 15, 2020	$1,021,155
CISA COVID ADULT CINCINNATI	Health R&D Services: Applied Research	Centers for Disease Control and Prevention	December 03, 2020	$1,414,103
CISA COVID MATERNAL STUDY	Health R&D Services: Experimental Development	Centers for Disease Control and Prevention	December 03, 2020	$1,195,207
SHEPHERD 2011 DOMAIN 1-A001 VE	Physical Science Applied Research/Exploratory Development R&D	Centers for Disease Control and Prevention	November 19, 2020	$467,417
"COVID-19 RELATED WORK" - THE PURPOSE OF THE EXTERNAL QUALITY ASSURANCE PROGRAM OVERSIGHT LABORATORY (EQAPOL) IS TO PROVIDE CONFIDENCE THAT INDIVIDUAL LABORATORIES GENERATE RELIABLE DATA TO SUPPORT VACCINE IMMUNOGEN ADVANCEMENT.	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	November 12, 2020	$613,865
BPCA PHARMACOLOGY STUDIES (TO2)- PERIOD OF PERFORMANCE: 9/14/18 - 9/13/22	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	October 28, 2020	$0
CISA DUKE UNIVERSITY MODIFICATION EXERCISE OPTION	Other Professional Services	Centers for Disease Control and Prevention	September 17, 2020	$213,409
COVID-19: NONHUMAN PRIMATE CORE VIROLOGY LABORATORY FOR AIDS VACCINE RESEARCH AND DEVELOPMENT	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	August 28, 2020	$573,990
FY 2020 COVID-19 BAA TOPIC 2 - DUKE	Physical Science Applied Research/Exploratory Development R&D	Centers for Disease Control and Prevention	August 24, 2020	$2,036,771
(COVID-19) THIS CONTRACT WILL PROVIDE LABORATORIES PERFORMING VIROLOGIC TESTING FOR NIAID-SPONSORED CLINICAL TRIALS (LABS) WITH A COMPREHENSIVE QUALITY ASSESSMENT PROGRAM FOR VIROLOGIC ASSAYS FOR HIV AND OTHER VIRAL PATHOGENS INCLUDING PROFICIENCY TE	AIDS Research R&D (Basic Research)	National Institutes of Health	July 06, 2020	$668,265
THE PURPOSE OF THIS CONTRACT IS TO CONDUCT, DEVELOP, ACQUIRE, IMPROVE, AND IMPLEMENT ASSAYS TO EVALUATE AND CHARACTERIZE THE HUMORAL IMMUNE RESPONSES OF NONHUMAN PRIMATES (NHP) THAT HAVE BEEN IMMUNIZED WITH CANDIDATE HIV OR SIV VACCINES OR INFECTED W	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	May 13, 2020	$996,426
THE PURPOSE OF P00003 IS TO EXTEND THE CONTRACT THROUGH JUNE 12, 2020 AT NO ADDITIONAL COST TO THE GOVERNMENT.	Physical Sciences R&D	Department of Homeland Security	May 01, 2020	$0
BPCA PHARMACOLOGY STUDIES - PERIOD OF PERFORMANCE: 9/14/18 - 9/13/22	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	March 31, 2020	$1,745,388

See this vendor on usaspending.gov ›

About this data

This data comes from the Federal Procurement Data System, which includes all contracts worth $10,000 or more. We look at all contracts that are tagged with the procurement code for COVID-19 or otherwise started in 2020 and contain “COVID-19” in the description. Department of Defense contracting data is subject to a 90-day delay before it appears in the data.